SAR.L
Sareum Holdings plc, a specialist drug development company, engages in the discovery and development of therapeutic drugs for cancer and autoimmune diseases. It develops small molecule therapeutic drugs based on its Sareum Kinase Inhibitor Library drug discovery platform. The company's product pipeline includes Checkpoint Kinase 1, Aurora+FLT3 kinase, and TYK2/JAK1 kinase. It has collaborations with Hebei Medical University Biomedical Engineering Center and Sierra Oncology, Inc. The company was founded in 2003 and is based in Cambridge, the United Kingdom.
Industry
Biotechnology
IPO Date
2004-10-11
Stock Exchange
LSE
Ticker
SAR.L
According to Sareum Holdings plc’s latest financial reports and current stock price. The company's current PE Ratio is -3.25. This represents a change of -35.25% compared to the average of -5.02 of the last 4 quarters.
The mean historical PE Ratio of Sareum Holdings plc over the last ten years is -23.22. The current -3.25 PE Ratio has changed 1.30% with respect to the historical average. Over the past ten years (40 quarters), SAR.L's PE Ratio was at its highest in in the December 2016 quarter at 51.36. The PE Ratio was at its lowest in in the June 2021 quarter at -49.31.
Average
-23.22
Median
-15.57
Minimum
-125.19
Maximum
56.16
Discovering the peaks and valleys of Sareum Holdings plc PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 663.27%
Maximum Annual PE Ratio = 56.16
Minimum Annual Increase = -400.82%
Minimum Annual PE Ratio = -125.19
| Year | PE Ratio | Change |
|---|---|---|
| 2025 | -4.45 | -58.22% |
| 2024 | -10.66 | -60.02% |
| 2023 | -26.66 | -57.75% |
| 2022 | -63.10 | -49.60% |
| 2021 | -125.19 | 663.27% |
| 2020 | -16.40 | 93.74% |
| 2019 | -8.47 | -42.53% |
| 2018 | -14.73 | -126.23% |
| 2017 | 56.16 | -400.82% |
| 2016 | -18.67 | 436.48% |
The current PE Ratio of Sareum Holdings plc (SAR.L) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-13.92
5-year avg
-46.01
10-year avg
-23.22
Sareum Holdings plc’s PE Ratio is less than Aptamer Group plc (-1.42), greater than Fusion Antibodies plc (-14.86), greater than Poolbeg Pharma PLC (-3.37), less than Inspiration Healthcare Group plc (-1.02), greater than IXICO plc (-6.83), greater than Arecor Therapeutics plc (-3.79), less than Genflow Biosciences plc (-3.10), greater than Cambridge Cognition Holdings Plc (-7.40), less than Renalytix Plc (-0.93), greater than OptiBiotix Health Plc (-36.18),
| Company | PE Ratio | Market cap |
|---|---|---|
| -1.42 | N/A | |
| -14.86 | N/A | |
| -3.37 | N/A | |
| -1.02 | N/A | |
| -6.83 | N/A | |
| -3.79 | N/A | |
| -3.10 | N/A | |
| -7.40 | N/A | |
| -0.93 | N/A | |
| -36.18 | N/A |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Sareum Holdings plc using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Sareum Holdings plc or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Sareum Holdings plc's PE Ratio?
How is the PE Ratio calculated for Sareum Holdings plc (SAR.L)?
What is the highest PE Ratio for Sareum Holdings plc (SAR.L)?
What is the 3-year average PE Ratio for Sareum Holdings plc (SAR.L)?
What is the 5-year average PE Ratio for Sareum Holdings plc (SAR.L)?
How does the current PE Ratio for Sareum Holdings plc (SAR.L) compare to its historical average?